 |
|
Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease
Ji Eun Ryu, Myeong Jun Song, Seok-Hwan Kim, Jung Hyun Kwon, Sun Hong Yoo, Soon Woo Nam, Hee Chul Nam, Hee Yeon Kim, Chang Wook Kim, Hyun Yang, Si Hyun Bae, Do Seon Song, U Im Chang, Jin Mo Yang, Sung Won Lee, Hae Lim Lee, Soon Kyu Lee, Pil Soo Sung, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon
Korean J Intern Med. 2022;37(5):958-968. Published online 2022 Aug 19 DOI: https://doi.org/10.3904/kjim.2021.486
|
|
Citations to this article as recorded by
 2025 KASL clinical practice guidelines for management of hepatitis C
Eun Sun Jang, Nae Yun Heo, Jae Yoon Jeong, Jung Gil Park, Do Seon Song, Eun Ju Cho, Chang Hun Lee, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jung
Clinical and Molecular Hepatology.2026; 32(1): 1. CrossRef Recent Advances in the Treatment of Chronic Hepatitis C
Suk Bae Kim
The Korean Journal of Gastroenterology.2025; 85(4): 475. CrossRef Hepatitis C Virus Infection in Hemodialysis Patients in the Era of Direct-Acting Antiviral Treatment: Observational Study and Narrative Review
Ioana Adela Ratiu, Adelina Mihaescu, Nicu Olariu, Cristian Adrian Ratiu, Bako Gabriel Cristian, Anamaria Ratiu, Mirela Indries, Simona Fratila, Danut Dejeu, Alin Teusdea, Mariana Ganea, Corina Moisa, Luciana Marc
Medicina.2024; 60(12): 2093. CrossRef Asunaprevir/daclatasvir
Reactions Weekly.2022; 1928(1): 76. CrossRef
|